Home
Phasebio Pharmaceuticals, Inc.

Phasebio Pharmaceuticals... Market Share Analysis for November 2025

The Investor Relations website contains information about PhaseBio Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Health > Biotechnology and Pharmaceuticals

Domainphasebio.com

Year Founded2002

Employees51 - 200

Annual Revenue$10M - $15M

Phasebio Pharmaceuticals, Inc.

Phasebio Pharmaceuticals, Inc. (including company regionals)

phasebio.com

See more website traffic and engagement information

Phasebio Pharmaceuticals, Inc. Revenue up to November 2025 is 10M - 15M

revenue generated by Phasebio Pharmaceuticals, Inc. top domains

Phasebio Pharmaceuticals, Inc. top domains revenue over 3 years

Revenue for Phasebio Pharmaceuticals, Inc. top domains

phasebio.com10M - 15M

See more with Sales Intelligence

Total visits to Phasebio Pharmaceuticals, Inc.'s top domains

Understand Phasebio Pharmaceuticals, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

phasebio.com706

See more with Sales Intelligence

Avg. visit duration in Phasebio Pharmaceuticals, Inc.'s top domains

Analyze Phasebio Pharmaceuticals, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

phasebio.com00:00:53

See more with Sales Intelligence

Avg. pageviews on Phasebio Pharmaceuticals, Inc.'s top domains

See how Phasebio Pharmaceuticals, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

phasebio.com2.16

See more with Sales Intelligence

Phasebio Pharmaceuticals, Inc. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

clinipace.comCompany NameClinipaceEmployees1001 - 5000HQUnited States, North Carolina, MorrisvilleAnnual revenue$200M - $500MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Phasebio Pharmaceuticals, Inc.

These are the website technologies, by industry, used by Phasebio Pharmaceuticals, Inc. top domains

Conversion & Analytics (8)

Google Analytics

Widget (6)

Twemoji

Advertising (3)

Google Adsense

Content Management System (3)

WordPress

More Technologies

9

See all

News & Signals from Phasebio Pharmaceuticals, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPhasebio has issues with potential breach of fiduciary duty claim.Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS).

NewsPhasebio had issues with Chapter 11 bankruptcy on Oct 31st '22.PhaseBio plans to file Chapter 11 bankruptcy and sell off its bentracimab assets under a "stalking horse: arrangement with an unnamed large pharmaceutical company, the company announced Monday.

NewsPhasebio receives financing of $40M in Series C.The center will be located near the Research Triangle Park in Cary, North Carolina where the company will, according to Novozymes, invest $36 million over the next three years and… PhaseBio Pharmaceuticals, Inc. a biopolymer-based drug manufacturer, has raised $40 million in a Series C round of funding, which includes a major share from AstraZeneca.